Surmodics, Inc. (SRDX)
NASDAQ: SRDX · IEX Real-Time Price · USD
26.17
0.00 (0.00%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Surmodics Revenue

Surmodics had revenue of $138.20M in the twelve months ending December 31, 2023, with 35.65% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $30.55M with 22.54% year-over-year growth. In the fiscal year ending September 30, 2023, Surmodics had annual revenue of $132.58M with 32.65% growth.

Revenue (ttm)
$138.20M
Revenue Growth
+35.65%
P/S Ratio
2.70
Revenue / Employee
$367,561
Employees
376
Market Cap
372.56M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023132.58M32.63M32.65%
Sep 30, 202299.95M-5.19M-4.93%
Sep 30, 2021105.14M10.27M10.83%
Sep 30, 202094.86M-5.21M-5.21%
Sep 30, 2019100.08M18.74M23.04%
Sep 30, 201881.34M8.22M11.25%
Sep 30, 201773.11M1.75M2.45%
Sep 30, 201671.37M9.47M15.30%
Sep 30, 201561.90M4.46M7.76%
Sep 30, 201457.44M1.31M2.33%
Sep 30, 201356.13M4.20M8.10%
Sep 30, 201251.93M-828.00K-1.57%
Sep 30, 201152.76M-1.73M-3.18%
Sep 30, 201054.49M-67.05M-55.17%
Sep 30, 2009121.53M24.48M25.23%
Sep 30, 200897.05M23.89M32.65%
Sep 30, 200773.16M3.28M4.69%
Sep 30, 200669.88M7.50M12.03%
Sep 30, 200562.38M12.64M25.42%
Sep 30, 200449.74M6.51M15.05%
Sep 30, 200343.23M13.74M46.61%
Sep 30, 200229.49M6.80M29.94%
Sep 30, 200122.69M4.41M24.15%
Sep 30, 200018.28M4.79M35.46%
Sep 30, 199913.49M3.72M37.99%
Sep 30, 19989.78M2.20M28.98%
Sep 30, 19977.58M1.40M22.63%
Sep 30, 19966.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MultiPlan 961.52M
DocGo 624.29M
Zynex 184.32M
Adaptive Biotechnologies 170.28M
Anika Therapeutics 166.66M
Harrow Health 130.19M
Heron Therapeutics 127.04M
Aquestive Therapeutics 50.58M
Revenue Rankings